Risks of reformulation: French patients complain after Merck modifies levothyroxine pills
Year: 2018
Type: article
Source: BMJ
DOI: 10.1136/bmj.k714
Author: Barbara Casassus
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2791924017
